Back to search

National and Kapodistrian University of Athens

Κλινική αξιολόγηση του νέου αποπτωτικού γονιδίου BCL2L12 στον καρκίνο του μαστού ως μοριακού δείκτη πρόγνωσης και ανταπρόκρισης στη χημειοθεραπεία

Abstract

dc:description

OBJECTIVES: BCL2-like 12 (BCL2L12) is a new member of the BCL2 gene family that was discovered and cloned by members of our group and found to be expressed in the mammary gland. Many genes of the BCL2 family were found to be implicated in breast carcinogenesis and to serve as possible prognostic markers. The aim of the present study was the quantification of BCL2L12 mRNA expression in order to assess its value as a prognostic tissue biomarker in breast cancer (BC).DESIGN AND METHODS: BCL2L12 mRNA levels were determined in a statistically significant sample size of cancerous (N=108) and adjacent non-cancerous (N=71) breast tissues using a highly sensitive quantitative real-time polymerase chain reaction (qRT-PCR) method. Relative quantification analysis was conducted using the comparative CT (2(-ΔΔC)T) method, whereas the association between BCL2L12 expression and clinopathological data, disease-free survival (DFS) and overall survival (OS) were estimated by statistical analysis.RESULTS: BCL2L12 mRNA expression was decreased in malignant samples compared to the histologically normal counterparts (p=0.012). Significant relationships between BCL2L12 expression and TNM stages (p=0.009), metastatic potential (p=0.012), tumor size (p=0.04) and age (p=0.024) were observed. Moreover, Kaplan-Meier and Cox univariate analyses indicated that BCL2L12 expression is associated with longer DFS, whereas multivariate analysis pointed out the independent favorable prognostic value of BCL2L12.CONCLUSIONS: According to our results, BCL2L12 mRNA expression is a favorable prognostic marker of DFS for BC patients, suggesting its possible application as a novel prognostic indicator of this malignancy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tzovaras, Alexandros
  • Τζοβάρας, Αλέξανδρος

Subjects

dc:subject × 15

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42562

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tzovaras, Alexandros; Τζοβάρας, Αλέξανδρος. Κλινική αξιολόγηση του νέου αποπτωτικού γονιδίου BCL2L12 στον καρκίνο του μαστού ως μοριακού δείκτη πρόγνωσης και ανταπρόκρισης στη χημειοθεραπεία. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42562